PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance

U.S. Markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
34.29-0.18 (-0.52%)
At close: 4:00PM EDT

34.40 0.11 (0.33%)
After hours: 4:27PM EDT

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close34.47
Bid0.00 x
Ask0.00 x
Day's Range34.23 - 34.56
52 Week Range29.41 - 37.39
Avg. Volume24,916,250
Market Cap204.2B
PE Ratio (TTM)29.23
Earnings DateN/A
Dividend & Yield1.28 (3.74%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters1 hour ago

    FDA approves Pfizer, German Merck immunotherapy for skin cancer

    U.S. health regulators on Thursday approved a drug developed by Merck KGaA and Pfizer Inc that helps the immune system to fight a rare form of skin cancer once it has spread to other parts of the body. The Food and Drug Administration said it approved Bavencio, known chemically as avelumab, to treat metastatic Merkel cell carcinoma (MCC) in patients 12 years and older. Bavencio belongs to a new class of oncology drugs called PD-L1 inhibitors that block a mechanism tumors use to evade detection from the immune system.

  • Investopedia6 hours ago

    Dogs of the Dow for 2017

    With all eyes focused on the Dow's recent rally, there is one investment strategy that couldn't care less.

  • Investopedia8 hours ago

    Pfizer’s Lyrica Ineffective for Sciatica Pain (PFE)

    A recent study has put a big question mark on the efficacy and safety of the most popular and established drug for sciatica pain